[Prostaglandin F2alpha- and 15-methyl-prostaglandin F2alpha-application for the treatment of severe uterine bleedings (author's transl)].
The paper reports on intravenous and intrauterine application of Prostaglandin F2alpha and its 15-methyl derivative for the treatment of severe uterine bleedings in obsteterics and gynaecology. The effectiveness of the compounds is demonstrated.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007744:Obstetric Labor Complications / Q000209:etiology; D006473:Postpartum Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D011460:Prostaglandins F / Q000008:administration & dosage / Q000627:therapeutic use*
D011460:Prostaglandins F
Prostaglandin-F2alpha-und 15-Methyl-Prostaglandin-F2alpha-Anwendung bei massiven uterinen Blutungen.